Compare Becton Dickinson and Co (BDX) vs UiPath Inc (PATH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs UiPath Inc — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while UiPath Inc trades at $12.02 (market cap $6.14B). The key difference: Becton Dickinson and Co is far larger — about 6.9× UiPath Inc's market cap, and Becton Dickinson and Co pays a 2.73% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.
| BDX | PATH | |
|---|---|---|
Market Cap | $42.39B | $6.14B |
Sector | Health | Technology |
52-Week High | $185.39 | $19.29 |
52-Week Low | $135.49 | $9.38 |
Enterprise Value | $58.85B | $4.92B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →
